Report offers ways to address cybersecurity challenges posed by legacy medical devices
The Food and Drug Administration on Nov. 16 announced a new report from government contractor MITRE, Next Steps Toward Managing Legacy Medical Device Cybersecurity Risks. The FDA acknowledges that legacy medical devices—those that cannot be reasonably protected against current cybersecurity threats—can pose significant risks to the health care sector. Legacy devices were legally put on the market and may still be broadly in use. To address this important security issue, the FDA contracted with MITRE to outline practical approaches and recommendations that can further drive sector-wide legacy device cyber risk management efforts.
Related News Articles
Headline
Microsoft Threat Intelligence is warning of a large scale, multistage phishing campaign that disproportionately targeted the health care sector, sending “code…
Headline
The Cybersecurity and Infrastructure Security Agency has launched a new initiative for critical infrastructure to defend against cyberattacks through proactive…
Headline
John Riggi, AHA national advisor for cybersecurity and risk, will moderate a webinar May 5 at 1 p.m. ET that will explore how bad actors are leveraging…
Headline
The AHA and Joint Commission May 4 announced the launch of the Cyber Resilience Readiness program, an initiative to help hospitals and health systems assess…
Headline
The Cybersecurity and Infrastructure Security Agency, National Security Agency and international partners have released guidance on adopting agentic artificial…
Headline
The Cybersecurity and Infrastructure Security Agency and other federal agencies released a joint guide yesterday for organizations to apply zero…